(Q40785220)

23 September 2017

Medicinal herbs: drugs or dietary supplements? (English)

1 reference

23 September 2017

1 reference

Chang J

1

1 reference

PubMed ID

10609549

23 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

23 September 2017

Biochemical Pharmacology

1 reference

23 September 2017

59

1 reference

23 September 2017

3

1 reference

23 September 2017

211-219

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

23 September 2017

1 reference

Clinical investigation of the antidepressant effectiveness of hypericum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

St John's wort as an antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Cognitive Performance Test: A New Approach to Functional Assessment in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

The bioavailability of ginkgolides in Ginkgo biloba extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Ma-huang strikes again: ephedrine nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Huperzine A as a pretreatment candidate drug against nerve agent toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Second generation cholinesterase inhibitors: effect of (L)-huperzine-A on cortical biogenic amines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

The future of fermented foods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

The effects of Chinese tea on the occurrence of esophageal tumors induced by N-nitrosomethylbenzylamine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Antimutagenic activity of green tea polyphenols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Reduced risk of esophageal cancer associated with green tea consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

A case-control study of gastric cancer and diet in northern Kyushu, Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Green tea consumption and the risk of pancreatic and colorectal cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

A comparative case-control study of colorectal cancer and adenoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Capsaicin-responsive NADH oxidase activities from urine of cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

The chemical and biological properties of hypericin--a compound with a broad spectrum of biological activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

The Activation of the c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase Signaling Pathways Protects HeLa Cells from Apoptosis Following Photodynamic Therapy with Hypericin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Ginkgo biloba extract (EGb 761) protects Na,K-ATPase activity during cerebral ischemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Echinacea-induced cytokine production by human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Cytokine production in leukocyte cultures during therapy with Echinacea extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900243-9

10.1016/S0006-2952(99)00243-9

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

10609549